Four Tree Island Advisory’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$852K Hold
3,384
0.28% 17
2026
Q1
$736K Buy
3,384
+60
+2% +$13.3K 0.37% 17
2025
Q4
$760K Hold
3,324
0.42% 15
2025
Q3
$766K Hold
3,324
0.49% 16
2025
Q2
$1.68M Sell
3,324
-58
-2% -$10.8K 1.18% 13
2025
Q1
$709K Sell
3,382
-17,576
-84% -$3.42M 0.5% 16
2024
Q4
$3.72M Buy
+20,958
New +$3.85M 2.57% 10

Other funds holding ABBV

Four Tree Island Advisory's ABBV Position: Q2 2026 in Review

Four Tree Island Advisory held its AbbVie (ABBV) position steady in Q2 2026 at 3,384 shares worth $852K. The position accounts for 0.28% of the portfolio, ranked #17.

Four Tree Island Advisory first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.72M in Q4 2024. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Four Tree Island Advisory held 3,384 shares of AbbVie worth $852K as of Q2 2026.
  • Four Tree Island Advisory left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.28% of Four Tree Island Advisory's portfolio in Q2 2026, its #17 holding.
  • Four Tree Island Advisory first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Four Tree Island Advisory's AbbVie position peaked at $3.72M in Q4 2024.
  • 4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Four Tree Island Advisory's 13F filing for Q2 2026, filed 7 Aug 2026.